Calendar : April 2026
WORLD MALBEC DAY
🍇
WORLD MALBEC DAY
April 17 — Malbec World Day
The vine that conquered the world from the Andean heights
🕐 Estimated reading time: 8–10 minutes
Published: April 17, 2026 • Annual Update
🖼️ Image: Malbec grapes in vineyards in Mendoza, Argentina — Wikimedia Commons
🖼️ Image: Copa de vino Malbec — Wikimedia Commons
Every April 17, the world raises its glass to pay tribute to a grape that survived plagues, crossed the Atlantic and found its definitive destination between the Andes and the Argentine sun. Malbec is not just a wine: it is the story of a national identity that today is present in 118 countries and generates foreign exchange for more than 400 million dollars a year.
🌍 Origin and History: From the Lot River to the Andes
Malbec is a variety of red grape whose cradle is found in the southwest of France, specifically in the region of Cahors – on the banks of the Lot River – where it is known as Côt or Auxerrois. For centuries it was one of the most prized varieties in Europe, crowning the tables of kings, tsars and empresses.
The tragedy came in 1877, when phylloxera – a tiny devastating aphid – devastated the 40,000 hectares of Gallic vineyards where Malbec reigned. French winegrowers lost their link with the vine. But while Europe mourned its vines, on the other side of the Atlantic the story was just beginning.
🇦🇷 The arrival in Argentina: Sarmiento and Michel Aimé Pouget
On April 17, 1853, President Domingo Faustino Sarmiento promoted the creation of the Quinta Normal and School of Agriculture in Mendoza, with the aim of modernizing Argentine viticulture. The French agronomist Michel Aimé Pouget was appointed to head the project, who introduced several European varieties: Merlot, Cabernet Sauvignon, Semillon and, among all of them, Malbec.
Mendoza received it generously: its altitude (600 to 1,500 meters above sea level), its thermal amplitude, its stony and arid soil, and its privileged Andean sun offered it the perfect conditions to develop a unique identity, impossible to replicate in any other corner of the world.
|
📜 "Malbec has a very particular flavor: an exuberance of violets that no other wine has, added to an ease of drinking thanks to what we call sweet tannin." — Alejandro Vigil, winemaker at Catena Zapata and president of Wines of Argentina. |
🖼️ Image: Vineyards in Mendoza with the Andes Mountains in the background — Wikimedia Commons
🗓️ Malbec World Day: How the Global Celebration Was Born
In 2011, Wines of Argentina (WofA) – the organization dedicated to positioning Argentine wine in the world – chose April 17 to establish Malbec World Day (MWD), in direct commemoration of that feat of Sarmiento and Pouget in 1853. The initiative was promoted by Lis Clément, then Marketing and Communication Manager of WofA, convinced that this celebration would help position Malbec as one of the jewels of world wine.
What started as a niche event became a global phenomenon: today more than 60 cities around the world coordinate celebrations supported by the Argentine Ministry of Foreign Affairs, the Argentine Wine Corporation (COVIAR) and the 2030 Strategic Wine Plan. Each year a different theme is created related to Malbec and Argentine culture, allowing each celebration to adapt to the local idiosyncrasy.
|
🏆 The MWD is considered one of the most successful brand launches in the history of Argentine wine, transforming Argentina into a protagonist of the global wine scene. |
📊 Malbec in Numbers: Argentina's Most Powerful Grape Variety
Data from the National Institute of Viticulture (INV) as of December 31, 2025 confirm the undisputed dominance of Malbec in the industry:
|
📊 Indicator |
📈 Fact |
🗓️ Year |
|
Hectares of Malbec |
46,890 ha |
2025 |
|
% of national red grapes |
42,6 % |
2025 |
|
Exports (value) |
USD 404.7 M |
2025 |
|
Countries that import it |
118 countries |
2024 |
|
Participation in internal varietals |
54 % |
2025 |
|
Direct jobs (sector) |
106.000+ |
2025 |
|
World's Highest Vineyard |
3.100 m s.n.m. — Jujuy |
History |
Malbec represents 23.9% of the total vine area in Argentina, and leads both domestic consumption (54% of all varietals sold) and exports. It is grown in 18 of the 24 Argentine provinces, although Mendoza concentrates 85.97% of the total production.
🌋 Lead region: Mendoza (Uco Valley, Luján de Cuyo, Maipú)
⛰️ Highest vineyard: Chucalezna, Jujuy — 3,100 m a.s.l.
🍾 Oldest bottle: 1912 — Finca El Paraíso, Maipú (estimated value: USD 1,000/glass)
🌐 Leading export market: United States (USD 129.49 M) followed by United Kingdom and Brazil
🖼️ Image: Map of Mendoza's wine region — Wikimedia Commons
🗺️ Terroir and Sensory Profiles: The Diversity of Malbec
One of the great strengths of Argentine Malbec is its ability to express different profiles depending on the terroir. The altitude, the composition of the soil, the thermal amplitude and the level of solar radiation shape completely different wines:
🏔️ Valle de Uco (1.000–1.500 m s.n.m.)
Wines of high elegance, with marked acidity, intense floral notes of violets and aromas of fresh red fruits (blueberries, cherry). Fine tannins and great ageing potential. Area of the great world terroirs: Altamira, Los Chacayes, Gualtallary.
🌿 Luján de Cuyo — DOC (600–900 m s.n.m.)
The oldest controlled designation of origin in Argentina and South America (1991). Fuller wines, with ripe fruit (plum, blackberry, cassis), greater body and sweet tannins. Century-old vines that give exceptional complexity.
☀️ San Juan and La Rioja
Warmer climates that produce Malbecs with very ripe fruits, greater natural sweetness and generous body. Ideal for blends and entry-level range.
🌵 Salta (Cafayate, 1.700 m s.n.m.)
The extreme altitude and thermal amplitudes of up to 25°C result in wines with vibrant acidity, spicy aromas and an unusual freshness for the variety.
|
🍷 Classic sensory profile of Argentine Malbec: Intense and bright violet color. Aromas of blackberry, plum, blueberry and violet. Palate with sweet and silky tannins. Long finish with notes of chocolate and spices. |
🍽️ Pairings: The Art of Accompanying Malbec
The gastronomic versatility of Malbec is one of its greatest attributes. Its balance between acidity and tannins adapts it to an extraordinary variety of dishes:
• 🥩 Grilled red meats: wide steak, picaña, chorizo, skirt steak — the classic pairing par excellence
• 🫙 Stews, stews and braised meats: the structure of Malbec complements the intense flavors
• 🧀 Mature cheeses: Manchego, Reggiano, Gruyère — the fat in the cheeses softens the tannins
• 🍄 Dishes with mushrooms and truffles: earthy notes blend masterfully
• 🍫 Dark chocolates and desserts with red fruits: the long finish creates surprising harmonies
• 🌮 Tacos and spicy Latin American cuisine: Malbec from Valle de Uco handles spices with grace
🏅 The most awarded Malbecs: The World Elite (2024–2025)
Argentine Malbec dominates major international competitions regularly. Here are some of the most recognized:
• 🥇 Zuccardi Finca Piedra Infinita Supercal Malbec 2021 — 100 Tim Atkin points (English reviewer)
• 🏆 Trivento Golden Reserve Malbec 2022 — Trophy categoría Malbec, International Wine Challenge (IWC) 2024, Londres
• 🥇 Microterroir Gravel & Stone Malbec 2020 (Finca Flichman) — Best in Show, Decanter World Wine Awards 2024
• ⭐ Terrazas de los Andes Reserva Malbec 2022 — The only Argentine wine recommended by Wine Spectator for value for money
• 🌟 Trapiche Terroir Series Finca Ambrosía SVB Malbec 2021 — 96 pts James Suckling, Top 100 Wines of Argentina 2024
• 🏅 Luigi Bosca De Sangre Malbec DOC 2022 — Gold Medal, IWC 2024
• 🌿 Artisan of Argento Organic Fairtrade Malbec 2022 — Gold Medal, IWC 2024
🖼️ Image: Bottle of Argentine Malbec — Wikimedia Commons
⚠️ Challenges and Future: Malbec in Search of Reinvention
Despite its global success, Malbec faces a moment of strategic reflection. In 2025, bulk Malbec exports fell 12% below the six-year average, and overall global wine consumption is at its lowest level in decades.
Analysts point out that Malbec could be going through "brand fatigue": consumers who drank hundreds of bottles of the variety could be looking for new emotions. The solution points to terroir, the diversity of styles and the communication of unique stories linked to specific plots.
The total cultivated area fell from 47,064 to 46,890 hectares in 2025, while the sector as a whole lost 3,726 hectares and 1,100 vineyards. However, wine tourism and high-end wines continue to grow strongly in Mendoza, San Juan and Salta.
|
🔮 The sector's commitment: diversification of terroirs, single vineyard wines, expansion in Asia and Oceania, and consolidation of wine tourism as a complementary economic engine. |
🎉 How to Celebrate World Malbec Day
The MWD is an opportunity to uncork a good bottle and also to learn more about the Argentine wine culture. Some ways to celebrate:
• 🍷 Organize a comparative tasting: Malbec from Luján de Cuyo vs. Uco Valley vs. Cafayate
• 🥩 Prepare a classic Argentinian barbecue with a Malbec Reserva from Mendoza
• 📚 Visit Malbec World Day in winesofargentina.org for events in your city
• 🎬 Watch documentaries about Mendoza's viticulture on streaming platforms
• ✈️ Plan a wine tourism trip to Mendoza: the Wine Route offers more than 100 wineries that can be visited
🍷 Cheers, and happy World Malbec Day! 🍷
"Argentina is a land of wines. Malbec achieved something more valuable than numbers: positioning an entire country as a protagonist on the global stage."
Sources: National Institute of Viticulture (INV) · Wines of Argentina (WofA) · La Nación · Malbec Report 2026 — argentina.gob.ar · Argentine Wine Observatory · EconArgy · Financial Area · Wikipedia.
WORLD HEMOPHILIA DAY
🩸 WORLD HEMOPHILIA DAY
April 17, 2026
"Diagnosis: first stage of care"
⏱️ Reading Time: 8–10 minutes | 📅 April 17, 2026 | 🌍 International edition
SEO: #Hemofilia #DíaMundialDeLaHemofilia #WHD2026 #TrastornosCoagulación #TerapiaGénica #SaludGlobal
|
🖼 [View online image] WHD 2026 Global Campaign — World Federation of Hemophilia |
📰 INTRODUCTION — BLOOD THAT DOES NOT CLOT
Every April 17, the world turns red to remember the more than 400,000 patients diagnosed with hemophilia on the planet — and the hundreds of thousands who still live without knowing they have it. World Hemophilia Day (WHD) is much more than a date in the health calendar: it is an urgent call to health systems, governments and civil society to close the diagnostic and therapeutic gap that condemns millions of people to bleed without care.
In 2026, the World Federation of Hemophilia (WFH) has chosen as its central motto "Diagnosis: first stage of care", focusing on an alarming fact: more than 75% of people with hemophilia in the world remain without a formal diagnosis. Without a name there is no treatment. Without treatment, hemorrhages destroy joints, damage organs, and in the most severe cases, can cost lives.
"More than 75% of people with hemophilia in the world have not yet received a formal diagnosis. Diagnosis is the first act of health justice."
🔬 WHAT IS HEMOPHILIA — WHEN BLOOD WON'T GIVE WAY
Hemophilia is a rare inherited bleeding disorder in which the blood cannot clot properly. The cause is the absence or deficiency of clotting factors: factor VIII in hemophilia A (the most common, with 80% of cases) and factor IX in hemophilia B, also known as Christmas disease. Without those factors, any cut, bump, or surgery can become an emergency; Internal bleeding – especially in joints and muscles – can occur spontaneously, without prior trauma.
The disease is congenital, chronic and non-contagious. It is transmitted linked to the X chromosome: females are carriers (with mild symptoms in many cases) and males are the ones who manifest it most severely. However, 30% of cases result from spontaneous mutations with no family history, which makes early diagnosis in a population with no known history even more critical.
|
🩸 Type A |
Factor VIII deficiency. 80% of cases. Prevalence: 24.6 per 100,000 male births. |
|
🩸 Type B |
Factor IX deficiency (Christmas disease). Prevalence: 5 per 100,000 male births. |
|
⚙️ Severity |
Mild (>5% of the factor), Moderate (1–5%), and Severe (<1%). Severe bleeding can cause spontaneous bleeding. |
|
🧬 Inheritance |
X-linked. It mainly affects males; Carrier women with variable symptoms. |
|
🔄 Acquired |
30% of cases arise from spontaneous genetic mutation, without family inheritance (acquired hemophilia). |
|
🖼 [See online image] Coagulation mechanism and role of Factor VIII/IX — Scientific illustration |
📊 NUMBERS THAT SPEAK — GLOBAL SNAPSHOT OF HEMOPHILIA
The numbers behind hemophilia expose not only the medical dimension of the disorder, but also the profound global inequity in access to diagnosis and treatment:
🌍 +400,000 people diagnosed with hemophilia worldwide (WFH, 2025)
⚠️ >75% of patients with hemophilia remain without a formal diagnosis
👨 1 in 10,000 male births has hemophilia A
👩 30% of cases are spontaneous, with no previous family history
💉 50%+ of newly diagnosed with severe hemophilia have no family history
🇦🇷 ~3,000 people with hemophilia in Argentina (WFH estimate)
In Latin America, the gaps in diagnosis and access to treatment are particularly marked. In Colombia, for example, 4,215 cases were registered in the first quarter of 2025, of which 807 corresponded to women – a figure that exposes the historical subdimension of female hemophilia. The Central region concentrates the highest proportion of hemophilia A cases, while rural areas have the highest late diagnosis rates.
|
🖼 [View online image] Global Hemophilia Prevalence Map — WFH 2025 |
📅 STORY OF THE DAY — FROM FRANK SCHNABEL TO THE WORLD
World Hemophilia Day did not arise at a bureaucratic desk. It was born from the personal struggle of Frank Schnabel, founder of the World Federation of Hemophilia, who experienced firsthand the weight of this disease. In 1989, the WFH established April 17, Schnabel's birthday, as Global Hemophilia and Other Inherited Bleeding Disorders Awareness Day.
Since then, the date has become a global event involving patient organizations, hospitals, governments, and scientific communities. Every year, iconic monuments and buildings around the world – from the Sydney Harbour Bridge in Australia to the CN Tower in Canada – are lit up in red as a symbol of solidarity with those living with bleeding disorders.
|
🎯 RECENT WORLD HEMOPHILIA DAY SLOGANS 2026: "Diagnosis: first stage of care" 2025: "Access for all: Women and girls also suffer from bleeding" 2024: "Equitable Access for All: Recognizing All Bleeding Disorders" 2023: "Access for All: Bleeding Prevention as a Global Standard of Care" |
♀️ HEMOPHILIA IN WOMEN AND GIRLS — THE INVISIBILIZATION THAT KILLS
For decades, hemophilia was culturally labeled as "the disease of kings" or "the disease of men." This narrative, although it has a genetic basis – the X-linked inheritance pattern makes the severe form more frequent in men – has left millions of women suffering from moderate or mild forms of the disease out of the health system.
Women with hemophilia face a triple challenge: the underestimation of their symptoms by health professionals, the absence of gender-specific diagnostic protocols, and the naturalization of excessive bleeding (menorrhagia, postpartum hemorrhage) as "normal." The result is a structural underdiagnosis that limits their access to treatment.
The diagnosis in women with bleeding disorders is more difficult to establish because the symptoms are not always so obvious, and in many cases they are attributed to other gynecological causes.
"More than 50% of people newly diagnosed with severe hemophilia have no prior family history. Every symptom ignored in a woman can be a nameless hemorrhage."
💉 THERAPEUTIC BREAKTHROUGHS — THE QUIET REVOLUTION
If anything has changed radically in the history of hemophilia, it is the therapeutic arsenal available. What in the twentieth century was a condemnation to a life of hemorrhages and severe disability, today can be managed with a quality of life close to normal—at least for those who have access to the most advanced treatments.
|
🧬 MAIN THERAPEUTIC OPTIONS IN 2026 🔵 Factor replacement therapy (FRT): Remains the therapeutic mainstay. Factor VIII or IX concentrates (plasma or recombinant) are infused intravenously, prophylactically or on demand. Extended half-life (EHL) products reduce the frequency of infusions. 🔴 Emicizumab (Hemlibra®): Bispecific antibody that mimics the function of Factor VIII. Subcutaneous administration with reduced frequency (weekly, biweekly or monthly). Effective even in patients with anti-FVIII inhibitors. Approved for hemophilia A. 🟠 Fitusiran (Qfitlia®): FDA approved. RNA interference that reduces hepatic antithrombin, rebalancing coagulation. Bimonthly subcutaneous administration. Active in both hemophilia A and B, with or without inhibitors. 🟢 Gene therapy: Adeno-associated vectors (AAVs) that transfer functional copies of F8 or F9 to the liver. Roctavian® (hemophilia A) available in the U.S. and Spain. Potential definitive cure; still in clinical consolidation. Phase III trials show promising results in long-term efficacy. |
Fitusiran represents a new therapeutic paradigm: instead of replacing the absent factor, it acts on natural coagulation inhibitors, favoring the generation of thrombin by an alternative route. Its RNA interference (RNAi)-based mechanism of action opens the door to a new era of molecularly precise treatments for hemophilia.
Gene therapy, on the other hand, is perhaps the most revolutionary bet. In clinical trials published in the New England Journal of Medicine, the SPK-8011 vector maintained Factor VIII expression in 16 of 18 patients for at least 52 months, significantly reducing bleeding episodes. It is not yet the definitive cure, but the gap is closing.
|
🖼 [View online image] Gene Therapy Diagram for Hemophilia A with AAV Vector |
"Hemophilia is no longer a disabling disease if it is treated properly from an early age. The future points to the consolidation of gene therapy as a curative treatment."
🌍 GLOBAL CHALLENGES — THE MAP OF INEQUALITY
Despite scientific advances, hemophilia remains a profoundly unequal disease. The most modern treatments — emicizumab, fitusiran, gene therapy — are available only in high-income countries. In low-resource regions, most patients depend on concentrates of basic factors, with frequent shortages that put their lives at risk.
The WFH estimates that more than 75% of people with hemophilia worldwide lack a formal diagnosis, and that the gap is even greater for other lesser-known clotting disorders, such as von Willebrand deficiency. Hundreds of thousands of people bleed without a name, without treatment and without hope of access to the health system.
|
⚠️ MAIN BARRIERS TO DIAGNOSIS AND TREATMENT 🔴 Lack of laboratory infrastructure for specialized hematological diagnosis 🔴 Shortage of haematologists and treatment centres in rural areas 🔴 High cost of clotting factors and non-replacement therapies 🔴 Structural underdiagnosis in women and girls 🔴 Absence of universal neonatal screening programs for coagulopathies 🔴 Digital divide and lack of national hemophilia registries in many countries |
The World Federation of Hemophilia maintains a humanitarian aid program that distributes factor concentrates to countries in economic difficulty and trains local medical personnel. In addition, it has proposed to the World Health Organization the inclusion of emicizumab and recombinant concentrates in the List of Essential Medicines – a battle that still awaits resolution.
👑 HEMOPHILIA IN HISTORY — FROM THE ROMANOVS TO TODAY
Hemophilia has one of the most documented historical chapters of any disease. Queen Victoria of the United Kingdom was a carrier of the mutated gene, which was passed down through her descendants to the royal houses of Spain, Russia and Prussia — which is why hemophilia was long known as "the royal disease" or "curse of the Romanovs."
The most dramatic case was that of Tsarevich Alexei Romanov, son of Tsar Nicholas II of Russia. The illness of little Alexei would mark the political history of the Russian Empire, facilitating the influence of the mystic Rasputin, whose supposed ability to calm the boy's bleeding crises gave him unusual power in the imperial court. The family was murdered by the Bolsheviks in 1918 without Alexei ever being able to receive adequate treatment.
|
🖼 [View Image Online] Tsarevich Alexei Romanov, the most famous case of hemophilia in history |
🤝 HOW TO PARTICIPATE — ACTIONS FOR APRIL 17
The WHD 2026 campaign invites the global community to come together through concrete actions:
📲 Share on social media with hashtags #WHD2026 #DíaMundialDeLaHemofilia #ElDiagnósticoImporta
🔴 Wear red on April 17 and photograph your participation with #NosIluminamosDeRojo
📚 Educate your community: explain what hemophilia is, its symptoms, and the importance of early diagnosis
💛 Support local hemophilia associations through donations or volunteerism
🌐 Visit worldhemophiliaday.org to download educational materials and official resources
🏛️ Ask your municipality or local government to light up an iconic building in red in solidarity
🔗 RESOURCES AND SOURCES — LEARN MORE
🔗 World Federation of Hemophilia (WFH) — World Hemophilia Day
🔗 FDA-approved Fitusiran (Qfitlia®) — Genotype
🔗 Gene therapy for hemophilia A — Genotypia
🔗 World Hemophilia Day — Patients' Classroom (Sacyl)
🔗 Hemophilia Situation in Colombia 2025 — High Cost Account
🔗 Infobae: Hemophilia, early detection and 2025 campaign
🔗 Healthcare Journal of Research — Hemophilia 2025 Clinical Review
✍️ EDITORIAL CLOSING — A DISEASE THAT DOES NOT WAIT
World Hemophilia Day is not an end in itself. It is a threshold. A reminder that science has advanced faster than health systems in too many countries. We have the tools—emicizumab, fitusiran, gene vectors—but those who need them most lack them. Health inequity is not a problem of scientific discovery; it is a problem of political will, financing and distributive justice.
While a child in Europe receives prophylaxis with emicizumab and grows up without joint damage, another child in sub-Saharan Africa bleeds without diagnosis, without a name for his disease and without access to any clotting factor. That is the fracture that the WHD 2026 puts on the table. Diagnosis, as the WFH emphasizes, is not the end of the road – it is the first step. And for millions, it's still an unattainable luxury.
"April 17 is not just a day. It is a collective demand: that no person in the world continues to bleed without a name, without diagnosis and without treatment."
Journalistic review prepared with informative rigor and up-to-date SEO techniques.
Sources: WFH/WFH, Genotipia, Infobae, High Cost Account (Colombia), Sacyl, Revista Sanitaria de Investigación.